You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API canakinumab

✉ Email this page to a colleague

« Back to Dashboard

Detailed excipient profiles for canakinumab

Excipient focus: HISTIDINE

canakinumab drug variants containing HISTIDINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	canakinumab	0078-0734
>Company	>Ingredient	>NDC

canakinumab drug variants not containing HISTIDINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HISTIDINE MONOHYDROCHLORIDE

canakinumab drug variants containing HISTIDINE MONOHYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	canakinumab	0078-0734
>Company	>Ingredient	>NDC

canakinumab drug variants not containing HISTIDINE MONOHYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

canakinumab drug variants containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	canakinumab	0078-0734
>Company	>Ingredient	>NDC

canakinumab drug variants not containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

canakinumab drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	canakinumab	0078-0734
>Company	>Ingredient	>NDC

canakinumab drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

canakinumab drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	canakinumab	0078-0734
>Company	>Ingredient	>NDC

canakinumab drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.